Illicit Drug Anti-Proliferation Act
The Illicit Drug Anti-Proliferation Act of 2003 is a United States federal law enacted as a rider within the PROTECT Act on April 30, 2003. A substantially similar Act was proposed during the previous Congress as the Reducing Americans' Vulnerability to Ecstasy Act (RAVE Act).
Legislative history
The RAVE Act was originally sponsored by Senator Joseph Biden, who was also the writer of the Illicit Drug Anti-Proliferation Act. Biden attached the legislation as a rider to the bill creating the popular AMBER Alert system, in order to get it passed without debate.
Purpose
The act authorized funds to educate parents and minors on the dangers of Ecstasy and other drugs. It also directed the United States Sentencing Commission to consider increasing federal sentencing penalties for offenses involving gamma-Hydroxybutyric acid (GHB). The law made it illegal for people to knowingly open, lease, rent, or maintain − whether permanently or temporarily − any place for the purpose of using, distributing or manufacturing any controlled substance. It also made it unlawful for a manager, employee or owner, to profit from, or make available for use, any place for the purpose of storing, distributing, manufacturing, or using a controlled substance.[1]
Criticism
The act has been criticized for disincentivizing venues from implementing harm reduction measures for fear of prosecution.[2]
See also
- Methylenedioxymethamphetamine (MDMA, "ecstasy")
- Retracted article on neurotoxicity of ecstasy
- Reducing Americans' Vulnerability to Ecstasy Act
References
- ↑ http://www.justice.gov/dea/ongoing/anti-proliferation_act.html
- ↑ Sullum, Jacob (30 December 2014). "Ignoring Drug Use At Musical Events Only Makes It More Dangerous". http://www.forbes.com. Forbes. Retrieved 22 February 2015. External link in
|website=
(help)
External links
Wikisource has original text related to this article: |
- Information about the act, from National Library for the Environment
- FAQs About The Illicit Drug Anti-Proliferation Act, from the Drug Enforcement Administration